SMART Wealth LLC Has $349,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

SMART Wealth LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 669 shares of the medical equipment provider’s stock after acquiring an additional 79 shares during the quarter. SMART Wealth LLC’s holdings in Intuitive Surgical were worth $349,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Berbice Capital Management LLC bought a new stake in Intuitive Surgical in the 4th quarter valued at $26,000. Godsey & Gibb Inc. increased its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the third quarter valued at about $33,000. Decker Retirement Planning Inc. acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the 3rd quarter valued at about $38,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 0.4 %

Shares of ISRG stock opened at $588.50 on Friday. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The business has a fifty day simple moving average of $553.03 and a 200 day simple moving average of $512.59. The company has a market cap of $209.61 billion, a P/E ratio of 91.81, a P/E/G ratio of 5.51 and a beta of 1.39.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 5,940 shares of company stock valued at $3,333,485. 0.80% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several research reports. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. JPMorgan Chase & Co. lifted their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Mizuho lifted their target price on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Finally, UBS Group upped their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.